The Oregon Health and Science University has collaborated with a Swedish biotech firm to bring a molecular test to market that could detect pancreatic cancer in its earliest stages. The test, ostensibly called IMMray PanCan-d, would analyze a patient’s immune system to detect signs of the cancer. It is being developed by Immunovia and OHSU’s…
OHSU Collaborates With Swedish Firm to Develop Pancreatic Cancer Assay
The Oregon Health and Science University has collaborated with a Swedish biotech firm to bring a molecular test to market that could detect pancreatic cancer in its earliest stages. The test, ostensibly called IMMray PanCan-d, would analyze a patient’s immune system to detect signs of the cancer. It is being developed by Immunovia and OHSU’s […]